IMTEC Oman 2026 — Muscat, 23–25 Nov 2026

Direct answer

The official organiser publishes exhibitor and visitor profiles, six named participant testimonials and live visitor, conference and exhibitor forms. It does not publish a complete named 2026 exhibitor, delegate or buyer directory. Separate official forms are live for visitors, conference delegates and exhibitor or sponsorship enquiries. The forms do not state a ticket, conference, stand or sponsorship price; obtain written eligibility, inclusions and commercial terms before commitment.

Editorial author
Horizon Strategies
Last verified in the editorial record
Scope
Oman · Healthcare & Life Sciences
Key facts and evidence
Fact or procedureRecorded evidenceAuthority and sourceChecked
Recorded dates23–25 Nov 2026Original source2026-10-28
Recorded cityMuscatOriginal source2026-10-28
Participation evidenceSeparate official forms are live for visitors, conference delegates and exhibitor or sponsorship enquiries. The forms do not state a ticket, conference, stand or sponsorship price; obtain written eligibility, inclusions and commercial terms before commitment.Original source2026-10-28

Limits and what this does not prove: Published scale figures are not labelled as a confirmed 2026 participant roster No complete named 2026 exhibitor, delegate or buyer directory is public Visitor, conference, stand and sponsorship prices are not stated on the forms

Event evidence

The official organiser publishes exhibitor and visitor profiles, six named participant testimonials and live visitor, conference and exhibitor forms. It does not publish a complete named 2026 exhibitor, delegate or buyer directory.

Separate official forms are live for visitors, conference delegates and exhibitor or sponsorship enquiries. The forms do not state a ticket, conference, stand or sponsorship price; obtain written eligibility, inclusions and commercial terms before commitment.

Qualify hospitals, clinics, distributors, insurers and medical-tourism partners by buyer role

Test demand for a defined treatment, device, digital-health or facility proposition

Map the regulatory, importer, clinical-evidence and after-sales steps required before market entry

Questions before commitment

Is the target a patient-referral partner, provider, distributor, regulator or institutional buyer?

Which Oman approvals, clinical evidence, import licences or local-service duties apply?

Which named meetings and participation format justify the mission cost?

Original sources